De Novo ZMYND8 variants result in an autosomal dominant neurodevelopmental disorder with cardiac malformations.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
09 2022
Historique:
received: 19 03 2022
revised: 07 06 2022
accepted: 10 06 2022
pubmed: 3 8 2022
medline: 9 9 2022
entrez: 2 8 2022
Statut: ppublish

Résumé

ZMYND8 encodes a multidomain protein that serves as a central interactive hub for coordinating critical roles in transcription regulation, chromatin remodeling, regulation of super-enhancers, DNA damage response and tumor suppression. We delineate a novel neurocognitive disorder caused by variants in the ZMYND8 gene. An international collaboration, exome sequencing, molecular modeling, yeast two-hybrid assays, analysis of available transcriptomic data and a knockdown Drosophila model were used to characterize the ZMYND8 variants. ZMYND8 variants were identified in 11 unrelated individuals; 10 occurred de novo and one suspected de novo; 2 were truncating, 9 were missense, of which one was recurrent. The disorder is characterized by intellectual disability with variable cardiovascular, ophthalmologic and minor skeletal anomalies. Missense variants in the PWWP domain of ZMYND8 abolish the interaction with Drebrin and missense variants in the MYND domain disrupt the interaction with GATAD2A. ZMYND8 is broadly expressed across cell types in all brain regions and shows highest expression in the early stages of brain development. Neuronal knockdown of the DrosophilaZMYND8 ortholog results in decreased habituation learning, consistent with a role in cognitive function. We present genomic and functional evidence for disruption of ZMYND8 as a novel etiology of syndromic intellectual disability.

Identifiants

pubmed: 35916866
pii: S1098-3600(22)00803-6
doi: 10.1016/j.gim.2022.06.001
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1952-1966

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest S.V.M., T.B.P., and M.J.G.S. are employees of GeneDx, Inc. All other authors declare no conflicts of interest.

Auteurs

Kerith-Rae Dias (KR)

Neuroscience Research Australia, Sydney, New South Wales, Australia; Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Colleen M Carlston (CM)

Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Laura E R Blok (LER)

Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.

Lachlan De Hayr (L)

School of Health and Behavioural Sciences, University of the Sunshine Coast, Maroochydore, Queensland, Australia; Sunshine Coast Health Institute, Birtinya, Queensland, Australia.

Urwah Nawaz (U)

Adelaide Medical School and Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.

Carey-Anne Evans (CA)

Neuroscience Research Australia, Sydney, New South Wales, Australia; New South Wales Health Pathology, Randwick Genomics Laboratory, Prince of Wales Hospital, Sydney, New South Wales, Australia.

Pinar Bayrak-Toydemir (P)

Department of Pathology, School of Medicine, University of Utah, Salt Lake City, UT; Molecular Genomics, ARUP Laboratories, University of Utah School of Medicine, University of Utah, Salt Lake City, UT.

Stephanie Htun (S)

Division of Medical Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, CA.

Ying Zhu (Y)

New South Wales Health Pathology, Randwick Genomics Laboratory, Prince of Wales Hospital, Sydney, New South Wales, Australia.

Alan Ma (A)

Department of Clinical Genetics, Children's Hospital Westmead, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia; Specialty of Genomic Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

Sally Ann Lynch (SA)

Department of Clinical Genetics, Temple Street Children's University Hospital, Dublin, Ireland.

Catherine Moorwood (C)

Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.

Karen Stals (K)

Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.

Sian Ellard (S)

Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.

Matthew N Bainbridge (MN)

Rady Children's Institute of Genomic Medicine, Rady Children's Hospital, San Diego, CA.

Jennifer Friedman (J)

Rady Children's Institute of Genomic Medicine, Rady Children's Hospital, San Diego, CA; Departments of Neurosciences and Pediatrics, University of California San Diego, San Diego, CA.

John G Pappas (JG)

Department of Pediatrics, Clinical Genetic Services, NYU Grossman School of Medicine, NYU Langone Health, New York, NY.

Rachel Rabin (R)

Department of Pediatrics, Clinical Genetic Services, NYU Grossman School of Medicine, NYU Langone Health, New York, NY.

Catherine B Nowak (CB)

The Feingold Center for Children, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Jessica Douglas (J)

The Feingold Center for Children, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Theodore E Wilson (TE)

Department of Medical & Molecular Genetics, Indiana University School of Medicine, Riley Hospital for Children at Indiana University Health, Indianapolis, IN.

Maria J Guillen Sacoto (MJ)

GeneDx, Gaithersburg, MD.

Sureni V Mullegama (SV)

GeneDx, Gaithersburg, MD.

Timothy Blake Palculict (TB)

GeneDx, Gaithersburg, MD.

Edwin P Kirk (EP)

New South Wales Health Pathology, Randwick Genomics Laboratory, Prince of Wales Hospital, Sydney, New South Wales, Australia; School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia; Centre for Clinical Genetics, Sydney Children's Hospital, Sydney, New South Wales, Australia.

Jason R Pinner (JR)

School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia; Centre for Clinical Genetics, Sydney Children's Hospital, Sydney, New South Wales, Australia.

Matthew Edwards (M)

Hunter Genetics, Hunter New England Health, New Lambton, New South Wales, Australia; School of Medicine, Western Sydney University, Penrith, New South Wales, Australia.

Francesca Montanari (F)

U.O. Genetica Medica, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Claudio Graziano (C)

U.O. Genetica Medica, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Tommaso Pippucci (T)

U.O. Genetica Medica, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Bri Dingmann (B)

Medical Genetics Department, Seattle Children's Hospital, Seattle, WA.

Ian Glass (I)

Medical Genetics Department, Seattle Children's Hospital, Seattle, WA.

Heather C Mefford (HC)

Center for Pediatric Neurological Disease Research, St. Jude Research, St. Jude Children's Hospital, Memphis, TN.

Takeyoshi Shimoji (T)

Department of Neurosurgery, Okinawa Pref. Nanbu Medical Center and Children's Medical Center, Okinawa, Japan; Okinawa Central Hospital, Okinawa, Japan.

Toshimitsu Suzuki (T)

Department of Neurodevelopmental Disorder Genetics, Institute of Brain Sciences, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Kazuhiro Yamakawa (K)

Department of Neurodevelopmental Disorder Genetics, Institute of Brain Sciences, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Haley Streff (H)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.

Christian P Schaaf (CP)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Institute of Human Genetics, Heidelberg University, Heidelberg University Hospital, Heidelberg, Germany.

Anne M Slavotinek (AM)

Division of Medical Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, CA.

Irina Voineagu (I)

School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia.

John C Carey (JC)

Division of Medical Genetics, Department of Pediatrics, University of Utah Health, Salt Lake City, UT.

Michael F Buckley (MF)

New South Wales Health Pathology, Randwick Genomics Laboratory, Prince of Wales Hospital, Sydney, New South Wales, Australia.

Annette Schenck (A)

Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.

Robert J Harvey (RJ)

School of Health and Behavioural Sciences, University of the Sunshine Coast, Maroochydore, Queensland, Australia; Sunshine Coast Health Institute, Birtinya, Queensland, Australia.

Tony Roscioli (T)

Neuroscience Research Australia, Sydney, New South Wales, Australia; Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia; New South Wales Health Pathology, Randwick Genomics Laboratory, Prince of Wales Hospital, Sydney, New South Wales, Australia; Centre for Clinical Genetics, Sydney Children's Hospital, Sydney, New South Wales, Australia. Electronic address: tony.roscioli@health.nsw.gov.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH